ChromaDex (United States)
Niagen Bioscience, formerly ChromaDex, is a bioscience сompany based in Los Angeles, California founded in 1999. The company operates in multiple sectors including reference standards, dietary supplements, and ingredient technology. Niagen Bioscience is publicly traded on the NASDAQ. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for ChromaDex (United States), United States, covering academic research published from 2003 to 2024. Read More.
Open Access Percentage
59%
Total
Publications
68
Total Open
Publications
40
Total
Citations
2.8K
Open Access
Percentage
59%
Total
Publications
68
Total Open
Publications
40
Total
Citations
2.8K
Breakdown
Publisher Open
32%
Both
21%
Other Platform Open
5%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 29%
10
Hybrid 37%
13
No Guarantees 34%
12
Other Platform Open
Domain 83%
15
Institution 28%
5
Preprint 6%
1
Other Internet 6%
1
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 15 |
Royal Netherlands Academy of Arts and Sciences | Institution | 3 |
Vrije Universiteit Amsterdam | Institution | 2 |
ZB MED - Information Centre for Life Sciences | Institution | 1 |
University of Oslo | Institution | 1 |
University of Florence | Institution | 1 |
Queen's University Belfast | Institution | 1 |
medRxiv | Preprint | 1 |
Massachusetts Institute of Technology | Institution | 1 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 1 |